Bpifrance

Chipiron develops portable MRI technology that uses quantum sensing to produce three-dimensional anatomical images at ultra-low magnetic fields. The devices are lightweight, portable, and priced at about one-tenth of conventional MRI systems. The technology supports disease detection, diagnosis, and treatment monitoring, with a focus on brain-related conditions, and aims to reduce fatality rates by expanding access to MRI imaging in diverse clinical settings.

H'ability specializes in providing immersive virtual reality (VR) therapeutic exercises that complement traditional rehabilitation methods. The company offers a wireless VR headset with customizable exercises targeting motor skills, balance, and cognitive functions. Their platform features real-time session personalization, detailed progress tracking with data analytics, and compatibility with additional rehabilitation tools. This enables healthcare professionals to deliver personalized, engaging, and efficient therapy sessions in clinical settings or at patients' homes, catering to various medical conditions.

Parallel builds AI agents that streamline healthcare admin workflows, seamlessly integrated to unlock efficiency at scale.

Fizimed SAS is a French company based in Strasbourg that specializes in developing medical devices aimed at addressing urinary incontinence in women. The company's flagship product, EMY, is a perineal probe designed to facilitate pelvic floor muscle reeducation. EMY connects to a mobile application, allowing users to engage in customized, interactive exercises that strengthen their pelvic floor while tracking their progress in real time. The device incorporates gamified elements to motivate users, offering various activities that turn exercises into enjoyable challenges. Founded in 2017, Fizimed is committed to balancing the safety and quality of medical devices with user-friendly technology, while actively working to destigmatize urinary incontinence—a common issue affecting one in ten women. Through social media initiatives, Fizimed fosters a community that encourages open discussions around this topic, aiming to empower women to take control of their health and well-being.

MSInsight is a bioinformatics startup specializing in the development of diagnostic and treatment response prediction solutions for microsatellite instability (MSI) cancers. The company offers a platform that utilizes next-generation sequencing data to analyze MSI status, a crucial biomarker in oncology. By providing actionable insights on this biomarker, MSInsight enables healthcare professionals to make informed decisions about patient care, particularly concerning treatment options such as immunotherapy. The focus on diagnostic and prognostic biomarkers of treatment response enhances the ability to improve overall patient outcomes in the oncology market.

GenSight Biologics is a clinical-stage biotechnology company focused on developing therapies for mitochondrial and neurodegenerative diseases of the eye. It uses gene therapy-based platforms, Mitochondrial Targeting Sequence and Optogenetics, to preserve or restore vision in patients with severe degenerative retinal diseases.

MB Therapeutics is a pharmaceutical company specializing in personalized medicine. It offers a patient-centric system for developing and producing customized medications, including evaluation services. The company excels in tailoring medication dosage, forms, and combining multiple active ingredients into a single unit, enabling healthcare professionals to enhance treatment precision and improve patient adherence.

EG 427 is a French biotechnology company specializing in gene therapy. It pioneers 'pinpoint gene therapy', focusing on HSV-1-based vectors to treat severe, chronic, and localized diseases, with an initial focus on neurogenic bladder disorders resulting from spinal cord injuries.

Ochy is a mobile application that uses video analysis and AI to evaluate users' running technique, identify areas for improvement, and provide personalized exercise plans to prevent injuries and enhance performance.

Coave Therapeutics specializes in developing gene therapies for rare ocular and central nervous system (CNS) diseases. Its platform enables targeted delivery of therapeutic genes to the CNS, enhancing autophagy and lysosomal function, with a focus on improving patient outcomes for conditions like ALS.

BiPER Therapeutics is a biotechnology company focused on developing innovative therapeutics, particularly targeting key proteins involved in cancer cell survival and treatment resistance. Its primary focus is on gastrointestinal cancers.

Vetbiolix is a veterinary biotechnology company dedicated to developing innovative therapeutic solutions for dogs and cats. The company focuses on the clinical development of first-in-class drug candidates aimed at treating and preventing diseases affecting pets, including periodontitis, osteoarthritis, and gut motility disorders. By prioritizing the creation of effective treatments for common health issues, Vetbiolix aims to enhance the quality of life for pets and their owners.

Biolevate is an AI-driven company focused on enhancing the healthcare sector through advanced technology. It provides innovative solutions for researchers and medical professionals by automating essential tasks such as document generation and literature monitoring. By leveraging sophisticated AI algorithms, Biolevate enables effective knowledge management that streamlines research workflows and accelerates scientific discovery. The company's tools intelligently filter extensive datasets, prioritizing relevant scientific information and offering customizable search options along with insightful data visualizations. Through this approach, Biolevate empowers clients to make informed decisions and facilitates significant advancements in medical research, ultimately aiming to improve patient care.

Theremia is a health technology company that leverages artificial intelligence to transform drug development, with a focus on neurological disorders. It employs advanced machine learning to optimize drug compounds for specific demographic groups, enhancing treatment effectiveness and reducing adverse effects.

Doado is a health technology company that specializes in developing mobile applications for back health management. Its primary product is an e-health application designed to guide users step by step in improving their back health and preventing Musculoskeletal Disorders. The application offers personalized video programs, expert advice from physiotherapists and doctors, and AI-driven progress tracking, enabling individuals and companies to maintain an active lifestyle and reduce the risk of chronic back pain.

Skezi is an e-cohort startup that believes that valuing the voices of patients, caregivers, families, and carers would enhance future health. SKEZI offers solutions adapted to all sectors of sensitive data through its subscription offer to its SaaS platforms.

Founded in 2016, Vaxinano is a biotechnology company dedicated to the preclinical and pharmaceutical development of human and veterinary vaccines. It specializes in creating vaccines and drug delivery systems that selectively target difficult pathogens like parasites, viruses, or bacteria.

Vetbiolix is a veterinary biotechnology company dedicated to developing innovative therapeutic solutions for dogs and cats. The company focuses on the clinical development of first-in-class drug candidates aimed at treating and preventing diseases affecting pets, including periodontitis, osteoarthritis, and gut motility disorders. By prioritizing the creation of effective treatments for common health issues, Vetbiolix aims to enhance the quality of life for pets and their owners.

Hepta Medical develops a microwave ablation platform designed for minimally invasive, nonsurgical treatment of early lung cancer. Its proprietary technology features an ablation catheter with integrated temperature sensing, enabling real-time monitoring and control of tissue ablation size.

Archeon Medical specializes in the development of innovative solutions aimed at enhancing the monitoring, diagnosis, and treatment of critically ill patients during prehospital care. The company utilizes artificial intelligence to create disruptive technologies that focus on improving ventilation quality in emergency medical services. Archeon Medical's products are practical, easy to use, and intuitive, providing emergency caregivers with real-time feedback on the quality of ventilation administered to patients. Through its commitment to advancing prehospital care, Archeon Medical seeks to optimize patient outcomes in critical situations.

UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

StarkAge Therapeutics is a discovery-stage biotechnology company focused on improving the quality of life for patients through innovative treatments. The company specializes in developing a platform that utilizes immunotherapy combined with cancer therapy to target and deplete senescent cells associated with age-related diseases. Its research and development efforts are aimed at addressing conditions such as idiopathic pulmonary fibrosis, neurodegenerative diseases, and metabolic dysfunctions, including hepatic fibroses. By leveraging its unique approach, StarkAge Therapeutics seeks to provide effective therapeutic options for managing these challenging health issues.

Biodol Therapeutics develops first-in-class therapies for chronic pain by targeting the FLT3 receptor, a receptor tyrosine kinase expressed on sensory neurons that triggers and sustains neuropathic pain. The company advances extracellular inhibitors of FLT3 to block ligand binding and disrupt pain signaling, with goals to reduce allodynia, hypersensitivity and spontaneous pain while preserving normal nervous system function. By pairing FLT3 inhibition with opioid analgesia, Biodol Therapeutics aims to enhance pain relief and potentially lower opioid-related safety risks. Founded in 2015 and based in Clapiers, France, the company collaborates with academic researchers to validate FLT3 as a therapeutic target for chronic pain.

MaaT Pharma, based in Lyon, France, is a clinical-stage biotechnology company founded in 2014 that specializes in the development of microbiome-based therapies aimed at treating diseases associated with gut microbiota imbalance. The company focuses on improving survival outcomes in patients with life-threatening conditions, particularly cancers and Graft-versus-Host Disease, a serious complication following allogeneic stem cell transplantation. MaaT Pharma has demonstrated proof of concept in acute myeloid leukemia patients and is actively expanding its pipeline to enhance outcomes in immunotherapy for solid tumors. Central to its research efforts is the GutPrint® platform, which facilitates the evaluation of drug candidates, identification of novel disease targets, and discovery of biomarkers related to microbiome-associated conditions.

Hephaistos Pharma is a biotechnology company developing an immunotherapy platform aimed at producing advanced oncology treatments. Its platform enhances commercialized antibodies by stimulating the immune system, turning 'cold' tumors into targets for immune response.

May Health is a healthcare company focused on addressing infertility related to Polycystic Ovary Syndrome (PCOS). The company has developed an innovative, minimally invasive procedure aimed at restoring ovulation in women with PCOS. This one-time treatment is performed transvaginally under ultrasound guidance, allowing for its execution in a clinical setting without the need for general anesthesia. May Health's approach seeks to provide patients with a more natural pregnancy experience by assisting the body to ovulate as it would naturally, thereby offering a less medicalized alternative to traditional fertility treatments.

Klineo is a healthcare platform focused on enhancing access to clinical trials for oncology patients. It features an intuitive and intelligent search interface that caters to both healthcare professionals and patients. The platform allows users to efficiently locate relevant clinical trials for specific conditions such as breast, skin, and lymphoma cancers, facilitating contact with trial centers and improving the overall trial search experience. By connecting patients and doctors with appropriate clinical research opportunities, Klineo aims to streamline the process of finding critical treatment options in the oncology field.

Pixacare is a medical imaging platform that converts smartphones into secure documentation tools for wound care. The app enables healthcare professionals to capture, manage, and monitor wound images and associated data, integrating with patient administration systems and electronic health records to streamline workflows. It supports home-care staff, surgeons, and dermatologists in monitoring chronic and post-surgical wounds, predicting complications, and saving time on visual assessments. The solution is CE-marked as a Class I digital medical device and is hosted on certified health data infrastructure to ensure data security and interoperability with healthcare IT systems.

Tribun Health specializes in digital health solutions for cancer detection. It develops innovative systems that enable diagnostic laboratories and pharmaceutical/biotech companies to manage, analyze, and share cellular images efficiently.

SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Chipiron develops portable MRI technology that uses quantum sensing to produce three-dimensional anatomical images at ultra-low magnetic fields. The devices are lightweight, portable, and priced at about one-tenth of conventional MRI systems. The technology supports disease detection, diagnosis, and treatment monitoring, with a focus on brain-related conditions, and aims to reduce fatality rates by expanding access to MRI imaging in diverse clinical settings.

HawkCell specializes in advanced magnetic resonance imaging (MRI) solutions for veterinary clinics and preclinical research labs. Utilizing non-ionizing, three-dimensional MRI technology adapted for diverse animal morphologies, the company offers sustainable systems enhanced by artificial intelligence algorithms to provide precise and insightful animal healthcare services.

Founded in 2017, Pixee Medical specializes in manufacturing medical equipment that aids in precise implant positioning. Utilizing computer vision and AI technologies, their camera-based systems enable surgeons to navigate prostheses with millimeter precision using smart glasses, enhancing orthopedic surgery affordability.

I.Ceram SA is a France-based company that specializes in the design, manufacture, and marketing of alumina bio-ceramic implants for various joints of the human body. Founded in 2005 and headquartered in Limoges, I.Ceram offers a range of implants for the ankle, knee, hip, spine, shoulder, wrist, skull, tibia, and foot, as well as osteosynthesis products. The company operates both domestically and internationally, emphasizing innovation and high-quality materials in its product offerings. I.Ceram is a subsidiary of Investissement Développement.

Ochy is a mobile application that uses video analysis and AI to evaluate users' running technique, identify areas for improvement, and provide personalized exercise plans to prevent injuries and enhance performance.

HUVY employs artificial intelligence to optimize dermatological treatment pathways and deliver critical medical information in real-time.

Callyope is a technology company focused on enhancing brain health monitoring through human-centered solutions. By developing a speech-based platform that utilizes natural language processing and signal processing techniques, Callyope enables caregivers to monitor patients' brain functionality more effectively. The platform allows for a detailed examination of patients' verbal productions, providing valuable insights that help identify relapses and inform treatment decisions. Ultimately, Callyope aims to improve the quality of life for patients while also contributing to a reduction in re-hospitalization rates.

GenSight Biologics is a clinical-stage biotechnology company focused on developing therapies for mitochondrial and neurodegenerative diseases of the eye. It uses gene therapy-based platforms, Mitochondrial Targeting Sequence and Optogenetics, to preserve or restore vision in patients with severe degenerative retinal diseases.

Steto Its mission is to create solutions for remote patient monitoring and digital diabetes therapies.

Astraveus is developing the Lakhesys platform, an end-to-end cell foundry for cell and gene therapy manufacturing. The platform uses deep process optimization and single-use microfluidic bioprocessors to produce autologous therapies with reduced inputs and infrastructure needs, lowering costs and logistical barriers. By enabling automated, patient-specific biomanufacturing, Astraveus aims to improve access to transformative CGTs. The system builds equipment tailored for each patient to use autologous cells, leveraging microfluidic chip technology to convert cells into therapeutic agents. The approach seeks to scale production of cell and gene therapies while minimizing environmental impact and resource use, supporting more sustainable manufacturing at lower cost.

Diamidex SAS, established in 2014 and based in Marseille, France, specializes in the development and production of rapid detection tests for legionella, a type of bacteria that can cause severe lung infections. The company offers turnkey test solutions, designed for both laboratory and field use, which provide semi-quantitative counts of microorganisms in water samples and industrial goods. Diamidex's products aim to enhance the accuracy and speed of microbial contamination detection, facilitating more efficient screening and data collection in research and testing environments.

BariaTek is a company specializing in innovative bariatric surgery solutions. It focuses on providing minimally invasive procedures that utilize trans-oral access techniques and implantable devices through endoscopy. By doing so, BariaTek aims to replicate the effects of traditional bariatric surgery while minimizing patient discomfort and recovery time. This approach allows patients to receive effective treatment for obesity and related diseases in a less invasive manner, thereby enhancing the overall patient experience and outcomes.

EverImmune specializes in developing live biotherapeutic products designed to enhance the efficacy of immunotherapy for cancer patients. Its flagship product, Oncobax®, aims to restore responsiveness to immune checkpoint inhibitors by leveraging gut microbiota.

Resolve Stroke, headquartered in Paris, is a HealthTech company dedicated to revolutionizing medical imaging. It specializes in enhancing ultrasound technology to extract more detailed information, enabling advanced diagnostics, particularly in neurology. The company's innovative software engines improve ultrasound contrast, resolution, and penetration depth, allowing for the visualization of micro-vessels through the human skull in 3D. With a global focus, Resolve Stroke aims to accelerate treatments for over 1 billion people affected by brain diseases. To date, it has secured €3 million in pre-seed funding to pioneer software-based ultrasound innovation.

Tribun Health specializes in digital health solutions for cancer detection. It develops innovative systems that enable diagnostic laboratories and pharmaceutical/biotech companies to manage, analyze, and share cellular images efficiently.

Teale is a prominent digital mental health platform that integrates psychology and technology to facilitate mental health care for individuals and organizations. The company offers personalized and engaging digital healthcare solutions, emphasizing the importance of subconscious well-being. Teale's approach includes individual support and collective workshops tailored to the specific needs of users, thereby enhancing the effectiveness of mental health initiatives. Through its curated network of mental health experts, Teale enables employees to assess their mental health status and access customized digital programs designed to promote their psychological resilience.

Aviwell is a company focused on enhancing animal health and growth through the development of natural and sustainable solutions. Utilizing a microbiota-based platform powered by artificial intelligence and machine learning, Aviwell operates at the intersection of digital and life sciences. The company aims to provide insights that improve animal health and performance while addressing the agri-food industry's challenges in sustainably feeding a growing global population. By prioritizing health and sustainability, Aviwell seeks to offer effective solutions at a reduced cost, ultimately contributing to better nourishment for the planet.

BioMAdvanced Diagnostics is a company focused on developing molecular diagnostic and biomarker tests that enhance patient care through individualized treatment strategies. Their innovative tests are designed to integrate seamlessly into existing diagnostic and treatment protocols, ensuring ease of use for healthcare personnel. By providing predictive scores and identifying biomarkers, BioMAdvanced Diagnostics enables clinicians to assess the immune response of patients and evaluate the risk of transplant rejection. This capability allows for improved anticipation and adaptation of treatment plans, ultimately aiming to enhance patient outcomes significantly.

Pollen Robotics specializes in developing humanoid service robots designed for interaction and manipulation of objects. Their robots are customizable and feature advanced robotic arms, enabling a wide range of applications across various industries.

Give smart ears to product. Saas B2B of an embedded AI to detect distress sounds (applied first to telecare companies).

X-Pressure is a medical device to measure cerebrospinal fluid pressure to better diagnose brain diseases.

SMAIO is a manufacturer of medical devices for spinal pathologies. They provide control over surgical procedures to the spine physician through a range of solutions.

Numa Health is a medical bioinformatics health technology company that focuses on empowering individuals to optimize their health capital and well-being. It has developed a digital health platform that offers tools designed to enhance users' commitment to their health. This platform facilitates the reinterpretation of blood test results, providing insights into bodily functions and overall health. By enabling users to measure, understand, and take actionable steps regarding their health, Numa Health aims to support individuals in their journey towards better health management.

CorWave is a company focused on developing innovative implanted cardiac support devices aimed at improving the quality of life for patients suffering from heart failure. Its flagship product, the CorWave LVAD, employs a unique undulating disc wave pumping mechanism, which replaces traditional high-speed impellers used in current continuous flow rotary pumps. This design significantly reduces trauma to blood, thereby minimizing complications such as clotting and bleeding. The CorWave pump generates a pulsatile flow that closely resembles the natural heartbeat, addressing a key limitation of existing LVADs that provide only continuous flow. Additionally, the device's low power consumption and compact size facilitate its potential for complete implantation, enhanced by a wireless energy transfer system. Through these advancements, CorWave aims to alleviate the burdens associated with heart failure and invasive surgical procedures.

IA Medical transforms raw data into intelligent patient knowledge. Its algorithms help to understand patient data, from diagnosis to follow-up, to support them with its conversational agents but also to set up a hybrid solution of cognitive and behavioral therapies.

Kairos Discovery is a biotechnology company focused on developing novel targeted cancer therapies. Its mission is to create innovative medicinal chemistry solutions that aim to transform the lives of cancer patients.

Maddie provides patient and practice management software for physiotherapists and other health professionals. It operates a healthcare platform that helps practitioners manage their practices by offering digital diaries, online appointment bookings, and a customizable and well-referenced website, enabling users to structure waiting lists, optimize schedules, and efficiently handle incoming requests.

Santé Académie is an innovative online training platform dedicated to enhancing the skills of healthcare professionals. Recognizing the evolving roles of caregivers and the rapid pace of medical knowledge advancement, the company offers high-quality educational videos accessible via web or mobile. Each course is structured into brief episodes lasting 5 to 15 minutes, catering to the busy schedules of doctors, nurses, pharmacists, and care assistants. The curriculum covers essential clinical and regulatory subjects relevant to daily practice, ensuring that participants receive up-to-date information. The courses are certified by the ANDPC and produced by leading experts from esteemed institutions. With a focus on continuous education and engagement, Santé Académie aims to improve patient care throughout the healthcare continuum, a mission supported by over 20,000 professionals and health institutions, including notable organizations such as GHU Paris psychiatrie & neurosciences and Service de Santé des Armées.

Deemea develops an AI-driven platform for clinical research, streamlining imaging data management. Its integrated copilot ensures efficiency and reliability in data processing.

Alentis Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for cancer and fibrotic diseases, including liver fibrosis, cirrhosis, and liver cancer. It pursues CLDN1-targeted approaches, developing anti-CLDN1 antibodies and antibody-drug conjugates to modify disease progression in CLDN1-positive cancers. Founded in 2019 and based in Basel, Switzerland, the company advances programs that aim to modulate the immune response and enhance anti-tumor activity while addressing liver-related conditions.

Odimma is a biotech company specializing in precision medicine aimed at developing personalized cancer immunotherapy solutions. The company has created an innovative immunotherapy drug that harnesses a unique platform, integrating three specific immune components designed to work together with the patient's immune system. When administered, this approach aims to induce and enhance immune responses, providing patients with the potential to eliminate tumors while minimizing adverse side effects. Through its focus on personalized treatment strategies, Odimma seeks to improve outcomes for cancer patients by tailoring therapies to individual needs.

Hemerion Therapeutics specializes in developing innovative cancer treatments, with a primary focus on advanced methods for treating glioblastoma, the most common and aggressive form of primary brain tumour. The company's proprietary platform combines photosensitizing molecules with advanced laser light technologies to enable precise targeting of resistant tumours.

Kayentis is a global leader in electronic clinical outcome assessment (eCOA) and Decentralized Clinical Trial solutions, focused on enhancing the efficiency and quality of data collection in clinical trials for the pharmaceutical, biotech, and contract research organization sectors. Founded in 2005, the company has specialized in eCOA solutions across various phases of clinical development, addressing over 200 indications in more than 20 therapeutic areas. Kayentis has adapted to the evolving clinical research landscape by offering a comprehensive suite of services aimed at supporting science-driven and patient-centric approaches. With operational capabilities spanning the USA, Europe, and Asia, Kayentis provides a range of adaptable tools to streamline electronic data capture, simplifying the clinical trial process for both patients and research sites.

Previa Medical operates a real-time health technology platform that analyzes patient data directly from electronic health records in hospitals. It identifies complication risks and enables healthcare professionals to provide timely treatment, potentially improving patient outcomes.

Previa Medical operates a real-time health technology platform that analyzes patient data directly from electronic health records in hospitals. It identifies complication risks and enables healthcare professionals to provide timely treatment, potentially improving patient outcomes.

BiPER Therapeutics is a biotechnology company focused on developing innovative therapeutics, particularly targeting key proteins involved in cancer cell survival and treatment resistance. Its primary focus is on gastrointestinal cancers.

Founded in 2017, Dianosic specializes in developing innovative medical devices for Ear, Nose, and Throat (ENT) conditions. The company's flagship product is the Active Resorbable Intranasal Scaffold (ARIS), a long-acting, patient-friendly device designed to treat chronic rhinitis and sinusitis, offering an alternative to daily medication.

Orthopus manufactures and distributes medical devices. They develop a range of robotic devices for arm mobility. Their supporter compensates for the weight of the arm to facilitate vertical movements. Their robotic device is used in an electric wheelchair and on a table.

WeLinQ is an online platform that provides free consultation services and easy messaging with therapists. They provide a practical substitute for in-person therapy with advantages including anytime messaging, adaptable scheduling, simple therapist switching, and the capacity to take part in sessions from any location.

Elis is a multi-services group operating in Europe and Brazil, specializing in the rental and maintenance of professional clothing, flat linen, and hygiene appliances. The company provides a wide range of tailored solutions, including services for washrooms, floor protection, beverages, cleanrooms, pest control, and medical waste management. With over 19,000 employees across 13 countries, Elis serves more than 240,000 businesses in various sectors, including hospitality, healthcare, industry, retail, and services. The company's extensive network of nearly 300 production and distribution centers, alongside 13 clean rooms, enables it to maintain strong proximity to its clients and deliver high-quality services efficiently. With over a century of experience, Elis has established itself as a leader in cleanliness, image, hygiene, and well-being services.

ErVaccine Technologies creates immunotherapies that integrate T-cell treatments with cancer vaccinations to meet a medical need for cold tumors. They are committed to identifying tumor epitopes that are physician. They come from endogenous retroviruses and are novel cancer epitopes. They use a bioinformatics-based strategy to find possible epitopes, which are then verified by proteomics and immunological testing.

Ganymed Robotics is a medical device company that develops robotics technologies for orthopedic surgeons, including a therapeutic device designed to improve precision in knee replacement procedures. Founded in 2018 and based in Paris, the company aims to enhance surgical accuracy, reduce operating times, and improve patient outcomes by integrating robotics into the orthopedic workflow.

Clarity is a clinical-stage company pioneering a new category of non-pharmacological treatments for neurodegenerative diseases. We develop a neuromodulation device combining immersive technology, AI and biosensors to deliver gamma sensory stimulation. Gamma waves’ sensory stimulation has been shown to significantly slow down Alzheimer's progression, reducing neurodegeneration and cognitive decline. Clarity takes a platform approach by enabling the customization of sensory stimulation protocols based on patient data, improving experience, efficacy and scalability across a wide range of indications. The company was founded by neuroscientists from UC Berkeley, and Oxford along with execs from OURA and Philips, and is supported by leading institutions such as UCSF's Neuroscape.

Remedee Labs SAS is a French company founded in 2016, dedicated to developing innovative solutions for chronic pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a personal endorphin stimulator that facilitates on-demand stimulation of the body’s natural endorphins to alleviate pain. Drawing on a decade of pre-clinical and clinical research, Remedee Labs aims to improve the quality of life for the 1.5 billion people worldwide suffering from chronic pain, particularly focusing on conditions such as fibromyalgia. By collaborating with medical practitioners, the company offers a patient-centered digital service platform that enhances the accessibility and effectiveness of endorphin-stimulation therapy for personal healthcare. As it continues to evolve, Remedee Labs plans to expand its platform to address additional chronic pain conditions, positioning itself as a leader in neuromodulation technology for pain management.

Jalon Therapeutics is a biotechnology company focused on developing cancer therapies by inactivating essential tumor signaling pathways through disruption of protein-protein interactions. The company aims to identify novel therapeutic targets, including through non-oncogene addiction, and to develop anticancer treatment strategies that advance patient outcomes.

Microphyt is a company focused on researching, developing, producing, and marketing natural algae-based products. It specializes in creating bioactive dietary supplements aimed at promoting weight loss and supporting brain health. The company utilizes an industrial-scale supply of microalgae biomass and extracts, ensuring the preservation of cell integrity while achieving commercial quantities of slow-growing or biofilm-forming species. This approach enables Microphyt to effectively cater to the demands of healthcare industries, particularly in the personal care and food sectors.

Founded in 2013, Meccellis Biotech specializes in the development of biological implants for tissue repair. Utilizing tissue and cellular engineering, they offer solutions tailored to various surgical specialties.

Livmed's is a software platform based in Nice, France, that specializes in home medicine delivery services. Founded in 2020, the company enables individuals to receive both prescription and non-prescription medications directly at their homes. The platform operates around the clock, ensuring timely access to essential healthcare products. Livmed's facilitates medicine delivery from local drugstores, allowing customers to obtain their medications conveniently, whether they have a prescription or not. Through its innovative approach, Livmed's enhances accessibility to healthcare while streamlining the medication procurement process for users.

Lys Therapeutics is a biotechnology company focused on developing therapies for patients with neurovascular and neurodegenerative disorders. The company is notable for its lead drug, Glunozumab, a monoclonal antibody that employs a novel mechanism of action. This drug hyperactivates both vascular and neuronal NMDA receptors, leading to off-target toxicity that can disrupt the blood-brain and blood-spinal cord barriers, resulting in neuronal excitotoxicity associated with conditions such as stroke and multiple sclerosis. Lys Therapeutics aims to address neuroinflammation and its effects on neurodegeneration through innovative biotherapies.

Lola Health is an insurance technology company that specializes in providing personalized complementary health insurance solutions. The firm focuses on enhancing traditional insurance offerings by including support for specific care pathways such as endometriosis, parenthood, postpartum depression, psychology, and alternative medicine. Lola Health's services are designed to assist businesses in retaining employees, attracting new talent, and improving overall performance. Key offerings include Angel Plus, an advisory platform that helps employees find solutions, telecommunications services, and psychological support. The company aims to make insurance more accessible and reduce risk by providing numerous assistance and prevention services.

Valneva is a vaccine company focused on developing prophylactic vaccines for infectious diseases with significant unmet medical needs. It has successfully commercialized two vaccines, IXIARO/JESPECT and DUKORAL, and is advancing candidates against Lyme disease, chikungunya virus, and COVID-19.

Guerbet is a healthcare company focused on medical imaging, with a history spanning 90 years. As a pioneer in contrast media, it is the only pharmaceutical group dedicated exclusively to this field. Guerbet operates in nearly 80 countries through a network of subsidiaries and distributors, providing a wide array of products for various imaging modalities, including CT scans, magnetic resonance imaging (MRI), ultrasound, and nuclear medicine. The company’s portfolio includes well-known brands such as Xenetix, Optiray, Dotarem, and Telebrix, among others. Additionally, Guerbet offers injectors and related medical devices aimed at enhancing patient diagnosis, prognosis, and overall quality of life.

BioMAdvanced Diagnostics is a company focused on developing molecular diagnostic and biomarker tests that enhance patient care through individualized treatment strategies. Their innovative tests are designed to integrate seamlessly into existing diagnostic and treatment protocols, ensuring ease of use for healthcare personnel. By providing predictive scores and identifying biomarkers, BioMAdvanced Diagnostics enables clinicians to assess the immune response of patients and evaluate the risk of transplant rejection. This capability allows for improved anticipation and adaptation of treatment plans, ultimately aiming to enhance patient outcomes significantly.

Founded in 2018, Incepto Medical develops AI-driven medical imaging applications. Its products include Qure.ai qER for head CTs, Qure.ai qXR for thorax abnormalities, Aidence Veye Chest for pulmonary nodule tracking, Icometric Icobrain for neurological disorder monitoring, and ScreenPoint Transpara for breast cancer detection. The company also operates Collective Minds Radiology, an online platform for case support and learning.

Tridek-One is a biotechnology company focused on developing immunomodulatory products aimed at addressing auto-immune and inflammatory disorders. The company's primary product is a peptide designed to maintain a cluster of truncated CD31 molecules at the membrane, which helps moderate overactive immune responses without complete blockade. By facilitating improved treatment options for medical companies, Tridek-One seeks to enhance the quality of life for patients suffering from these conditions.

Cuure is a company specializing in personalized vitamins and supplements designed to meet individual health needs. Through a combination of health questionnaires and DNA analysis, Cuure creates customized supplement plans aimed at optimizing overall wellness. The company's platform offers tailored recommendations based on scientific research, ensuring that users receive the appropriate dosages of vitamins, minerals, and plant-based ingredients suited to their specific health goals and body chemistry. Additionally, Cuure incorporates a tracking application to help individuals foster wellness habits, making it easier for them to integrate these personalized solutions into their daily routines.

Apmonia Therapeutics develops peptide-based therapies targeting the tumor microenvironment to improve cancer patient outcomes. Their focus includes glioblastoma, ovarian, colorectal, and pancreatic cancers.

Founded in 2019, DeepLife is a biotechnology company based in Paris, France. It specializes in developing digital twins of cells to accelerate drug discovery. The company uses advanced modeling techniques and deep learning on multi-omics data to simulate cell responses and identify new targets, biomarkers, and potential drug candidates.

Chipiron develops portable MRI technology that uses quantum sensing to produce three-dimensional anatomical images at ultra-low magnetic fields. The devices are lightweight, portable, and priced at about one-tenth of conventional MRI systems. The technology supports disease detection, diagnosis, and treatment monitoring, with a focus on brain-related conditions, and aims to reduce fatality rates by expanding access to MRI imaging in diverse clinical settings.

Qairn is a company that specializes in digitizing regulatory processes through its software-as-a-service (SaaS) platform. This platform is designed to streamline and secure mandatory procedures for various healthcare sectors, including laboratories, medical device manufacturers, and biotechnology firms. Qairn offers services such as the review and validation of promotional materials, submission to the ANSM, and the validation of regulated content. By simplifying these processes, Qairn helps healthcare manufacturers manage their regulatory requirements efficiently, thereby reducing risks associated with compliance and enhancing workflow management.

SPART supports companies in the process of improving quality of life at work by offering solutions to activate health and well-being practices each day in a professional environment. They are partners for corporate sporting challenges. They enable everyone to achieve their full potential through innovative physical activities within the company.

Nurea develops AI-powered medical imaging software that transforms standard 2D scans into 3D reconstructions of arterial systems, enabling early detection of cardiovascular and neurovascular conditions such as aneurysms. The solution automates quantitative image analysis, providing accurate, operator-independent assessments that integrate seamlessly into hospital workflows. By allowing clinicians to monitor structural changes over time, the platform supports precise and reliable diagnoses for vascular surgeons and other healthcare professionals.

Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations. Sonio combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. It assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitate the sharing of images with patients and other health professionals.

Healshape is a biotech startup dedicated to developing natural breast reconstruction solutions for women through innovative regenerative medicine techniques. The company specializes in creating bioprostheses using 3D bioprinting technology, offering an alternative to traditional breast reconstruction methods. By focusing on natural products, Healshape aims to provide women with long-lasting, aesthetically pleasing results, helping them regain their self-confidence following surgery.

Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

Implicity develops a software-as-a-service remote monitoring platform for patients with connected pacemakers and defibrillators. The platform collects and analyzes data from cardiac electronic implants, using an artificial intelligence module to sort and summarize information and assess the criticality of alerts within the patient’s medical context. This enables cardiology and other healthcare professionals to automate remote monitoring, consolidate patient telemetry on a single platform, and support timely clinical decision-making to deliver high-quality care.

Hemerion Therapeutics specializes in developing innovative cancer treatments, with a primary focus on advanced methods for treating glioblastoma, the most common and aggressive form of primary brain tumour. The company's proprietary platform combines photosensitizing molecules with advanced laser light technologies to enable precise targeting of resistant tumours.

Ribonexus is a biotechnology company dedicated to developing innovative therapies aimed at treating cancer. The firm focuses on creating a pipeline of small molecules that specifically target the eukaryotic translation initiation factor-4A to address resistance in patients who have become unresponsive to existing targeted therapies. With a primary emphasis on melanoma, Ribonexus aims to enhance the effectiveness of current treatments by restoring sensitivity to them in patients whose cancers have developed resistance. Through its research and development efforts, Ribonexus seeks to contribute meaningful advancements in oncology and improve treatment outcomes for patients facing challenging cancer types.

Ribonexus is a biotechnology company dedicated to developing innovative therapies aimed at treating cancer. The firm focuses on creating a pipeline of small molecules that specifically target the eukaryotic translation initiation factor-4A to address resistance in patients who have become unresponsive to existing targeted therapies. With a primary emphasis on melanoma, Ribonexus aims to enhance the effectiveness of current treatments by restoring sensitivity to them in patients whose cancers have developed resistance. Through its research and development efforts, Ribonexus seeks to contribute meaningful advancements in oncology and improve treatment outcomes for patients facing challenging cancer types.

Guard Medical specializes in developing innovative medical devices. Its flagship product is NPseal™, designed to facilitate easy-to-use and cost-effective negative pressure wound therapy for closed surgical incisions.